Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic primary bone dysplasia disorder characterized by disproportionate short stature with shortening of upper and lower limbs, short and broad fingers with short hands, narrowed chest with rib abnormalities and pectus excavatum, abnormal chondral calcifications (incl. larynx, trachea and costal cartilages) and facial dysmorphism (frontal bossing, hypertelorism, prominent eyes, short flat nose, wide nostrils, high-arched palate, long philtrum). Platyspondyly (esp. of cervical spine) and abnormal epiphyses and metaphyses are observed on radiography. Atlantoaxial instability causing spinal compression and recurrent respiratory disease are potential complications that may result lethal.
Features include always present findings: Short finger, Broad palm, Broad long bones, and Platyspondyly and others; and very common findings: Hypertelorism and Concave nasal ridge. 63 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 4 | Short finger, Disproportionate short-limb short stature, Short phalanx of finger |
DDR2 encodes discoidin domain receptor tyrosine kinase 2 (855 aa). Tyrosine kinase involved in the regulation of tissues remodeling. Highest expression in Cells Cultured fibroblasts (110.2 TPM) and Colon Sigmoid (87.2 TPM).
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome is caused by mutations in the DDR2 gene on chromosome 1.
The DDR2 protein participates in Collagen type I, II, III, V, X fibrils pathway.
DDR2 is classified as a druggable target (Clinically Actionable, Druggable Genome, Kinase, Transcription Factor, and Tyrosine Kinase categories) with score 1.6.
Genetic testing for DDR2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features, 2 very common features, 13 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Data assembled from 6 of 12 sources · Last updated Sep 21, 2026, 2:33 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Bones and joints |
4 |
Broad long bones, Abnormal calcification of the carpal bones, Short long bone |
Brain and nerves | 4 | Global developmental delay, Calcification of falx cerebri, Depressed nasal ridge |
Muscles | 3 | Low muscle tone (hypotonia), Knee flexion contracture, Elbow flexion contracture |
Head and neck | 2 | Broad face, High palate |
Lungs and breathing | 2 | Recurrent pneumonia, Restrictive ventilatory defect |
Growth and development | 1 | Disproportionate short-limb short stature |